These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1263587)

  • 1. Attempts of application of the immunotherapy of proliferative and aplastic diseases of the hemopoietic system with thymic hormone.
    Aleksandrowicz J
    Mater Med Pol; 1976; 8(1):58-64. PubMed ID: 1263587
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the thymus and thymic humoral factors in immunotherapy of aplastic and proliferative diseases of the hemopoietic system.
    Aleksandrowicz J; Skotnicki AB
    Acta Med Pol; 1976; 17(1):1-17. PubMed ID: 769487
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunotherapy of proliferative hemocytopathies by transplantation of thymus from myasthenic patients].
    Rzepecki WM; Aleksandrowicz J; Szmigiel Z; Turowski G; Lukasiewicz M; Skotncki A; Lisiewicz J
    Pol Tyg Lek; 1973 Nov; 28(47):1837-40. PubMed ID: 4771535
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of myasthenic thymus fragments transplantation on the immune state of patients with proliferative and aplastic diseases of the haematopoetic system.
    Szmigiel Z; Turowski G; Rzepecki WM; Aleksandrowicz J; Skotnicki AB
    Acta Med Pol; 1975; 16(2):61-82. PubMed ID: 1146608
    [No Abstract]   [Full Text] [Related]  

  • 5. [An attempt of immunological stimulation of patients with proliferative and applastic diseases of the haematopoietic system by means of calf's thymus extract (TFX) (author's transl)].
    Aleksandrowicz J; Szmigiel Z; Czarnecki J; Turowski G; Skotnicki AB
    Przegl Lek; 1975; 32(2):277-9. PubMed ID: 1167699
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary results of transplantation of thymus originating from patients with myasthenia gravis to patients with leukemia and those with Hodgkin's disease].
    Rzepecki WM; Lukasiewicz M; Aleksandrowicz J; Szmigiel Z; Skotnicki A; Lisienicz J
    Przegl Lek; 1973; 30(6):518-20. PubMed ID: 4732446
    [No Abstract]   [Full Text] [Related]  

  • 7. [Surgical treatment methods in blood diseases].
    Abdulkadyrov KM; Kargin VD; Senchilo EA; Ushakova EA; Popova TI
    Vestn Khir Im I I Grek; 1982 Oct; 129(10):103-6. PubMed ID: 6758297
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract.
    Shanker A; Singh SM
    Neoplasma; 2003; 50(4):272-9. PubMed ID: 12937840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial of immunologic stimulation with thymic extract (TFX) in untreated chronic lymphocytic leukemia.
    Wazewska-Czyzewska M; Aleksandrowicz J; Turowski G; Blicharski J; Dobrowolski J; Dolezalowa M
    Acta Med Pol; 1976; 17(2):97-110. PubMed ID: 937067
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on thymus products. 3. Epithelial origin of the serum thymic factor.
    Dardenne M; Papiernik M; Bach JF; Stutman O
    Immunology; 1974 Aug; 27(2):299-304. PubMed ID: 4421188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of immunologic competence of neonatally thymectomized mice by thymic grafts.
    Hallenbeck GA; Kubista TP; Shorter RG
    Rev Surg; 1970; 27(1):59. PubMed ID: 5416524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correction of the T immunological system deficit in experimental and clinical tuberculosis].
    Alexandrova AE; Vasiliev AV; Greimer MS; Zabolotnîh NV; Kniajeţkaia EJ; Kozlova NV; Talanova AG; Scerbakova NM
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(2):115-22. PubMed ID: 6264576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of immune functions and subsequent suppression of blood pressure in spontaneously hypertensive rats by allogeneic, xenogeneic thymus grafts or injection of thymus extracts.
    Ba DN; Takeichi N; Kobayashi H
    Chin Med J (Engl); 1981 Jun; 94(6):369-74. PubMed ID: 6788478
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic effects of a purified thymic hormone, thymosin.
    Hardy MA; Goldstein AL; White A
    Surg Forum; 1972; 23(0):305-7. PubMed ID: 4601093
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pros and cons of the use of immunotherapeutic procedures with special reference to adoptive immunotherapy in proliferative diseases].
    Schneiberg K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(3):337-57. PubMed ID: 6159273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of transplantation tolerance by allogeneic thymus grafts.
    Schaller RT; Stevenson JK
    Surg Forum; 1965; 16():213-5. PubMed ID: 5319659
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antilymphocyte antisera therapy in haematologic disease (author's transl)].
    Haematologica; 1976 Jun; 61(2):131-40. PubMed ID: 820604
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic liver diseases: secondary thymic insufficiency and immunocorrection with T-activin].
    Sarkisian SV
    Klin Med (Mosk); 1994; 72(6):45-8. PubMed ID: 7898010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymus-mediated tolerance to cellular alloantigens.
    Vojtísková M; Lengerová A
    Transplantation; 1968 Jan; 6(1):13-24. PubMed ID: 4866735
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of the thymus in tolerance. IV. Specific tolerance to homografts in neonatally thymectomized mice grafted with thymus from tolerant donors.
    Toullet FT; Waksman BH
    J Immunol; 1966 Nov; 97(5):686-92. PubMed ID: 5332785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.